Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Brent R. Logan PhD

Brent R. Logan PhD

Director, Professor

Institution: Medical College of Wisconsin
Department: Institute for Health and Equity
Division: Biostatistics
Program: Research

Member of the Cancer Center


Research Experience

  • Multiple Comparison Procedures
  • Publications

  • The Effect of Aging and Pre-Donation Comorbidities on the Related PBSC Donor Experience: A Report from the Related Donor Safety Study (RDSafe). (Pulsipher MA, Logan BR, Chitphakdithai P, Kiefer DM, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Bunin NJ, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Shaw BE, Confer DL) Biol Blood Marrow Transplant 2018 Nov 10 PMID: 30423480 11/14/2018    
  • Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at 1-year compared to unrelated donors. (Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Parameswaran V, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Confer DL, Shaw BE) Haematologica 2018 Oct 31 PMID: 30381298 11/02/2018    
  • SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery. (Haddad E, Logan BR, Griffith LM, Buckley RH, Parrott RE, Prockop SE, Small TN, Chaisson J, Dvorak CC, Murnane M, Kapoor N, Abdel-Azim H, Hanson IC, Martinez C, Bleesing JJH, Chandra S, Smith AR, Cavanaugh ME, Jyonouchi S, Sullivan KE, Burroughs L, Skoda-Smith S, Haight AE, Tumlin AG, Quigg TC, Taylor C, Dávila Saldaña BJ, Keller MD, Seroogy CM, Desantes KB, Petrovic A, Leiding JW, Shyr DC, Decaluwe H, Teira P, Gillio AP, Knutsen AP, Moore TB, Kletzel M, Craddock JA, Aquino V, Davis JH, Yu LC, Cuvelier GDE, Bednarski JJ, Goldman FD, Kang EM, Shereck E, Porteus MH, Connelly JA, Fleisher TA, Malech HL, Shearer WT, Szabolcs P, Thakar MS, Vander Lugt MT, Heimall J, Yin Z, Pulsipher MA, Pai SY, Kohn DB, Puck JM, Cowan MJ, O'Reilly RJ, Notarangelo LD) Blood 2018 Oct 25;132(17):1737-1749 PMID: 30154114 PMCID: PMC6202916 08/30/2018       2 Citations
  • Testing for center effects on survival and competing risks outcomes using pseudo-value regression. (Wang Y, Logan BR) Lifetime Data Anal 2018 Jul 05 PMID: 29978275 07/07/2018    
  • A phase II/III randomized, multicenter trial of prednisone/sirolimus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft--host disease: BMT CTN 0801. (Carpenter PA, Logan BR, Lee SJ, Weisdorf DJ, Johnston L, Costa LJ, Kitko CL, Bolaños-Meade J, Sarantopoulos S, Alousi AM, Abhyankar S, Waller EK, Mendizabal A, Zhu J, O'Brien KA, Lazaryan A, Wu J, Nemecek ER, Pavletic SZ, Cutler CS, Horowitz MM, Arora M, BMT CTN.) Haematologica 2018 Nov;103(11):1915-1924 PMID: 29954931 06/30/2018    
  • Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression. (Jacobsohn DA, Loken MR, Fei M, Adams A, Brodersen LE, Logan BR, Ahn KW, Shaw BE, Kletzel M, Olszewski M, Khan S, Meshinchi S, Keating A, Harris A, Teira P, Duerst RE, Margossian SP, Martin PL, Petrovic A, Dvorak CC, Nemecek ER, Boyer MW, Chen AR, Davis JH, Shenoy S, Savasan S, Hudspeth MP, Adams RH, Lewis VA, Kheradpour A, Kasow KA, Gillio AP, Haight AE, Bhatia M, Bambach BJ, Haines HL, Quigg TC, Greiner RJ, Talano JM, Delgado DC, Cheerva A, Gowda M, Ahuja S, Ozkaynak M, Mitchell D, Schultz KR, Fry TJ, Loeb DM, Pulsipher MA) Biol Blood Marrow Transplant 2018 Oct;24(10):2040-2046 PMID: 29933069 PMCID: PMC6239928 06/23/2018       1 Citations
  • Repurposing existing medications as cancer therapy: design and feasibility of a randomized pilot investigating propranolol administration in patients receiving hematopoietic cell transplantation. (Knight JM, Kerswill SA, Hari P, Cole SW, Logan BR, D'Souza A, Shah NN, Horowitz MM, Stolley MR, Sloan EK, Giles KE, Costanzo ES, Hamadani M, Chhabra S, Dhakal B, Rizzo JD) BMC Cancer 2018 May 24;18(1):593 PMID: 29793446 PMCID: PMC5968588 05/26/2018    
  • B-cell differentiation and IL-21 response in SCID patients after hematopoietic stem cell transplantation. (Miggelbrink AM, Logan BR, Buckley RH, Parrott RE, Dvorak CC, Kapoor N, Abdel-Azim H, Prockop SE, Shyr D, Decaluwe H, Hanson IC, Gillio A, Dávila Saldaña BJ, Eibel H, Hopkins G, Walter JE, Whangbo JS, Kohn DB, Puck JM, Cowan MJ, Griffith LM, Haddad E, O'Reilly RJ, Notarangelo LD, Pai SY) Blood 2018 Jun 28;131(26):2967-2977 PMID: 29728406 PMCID: PMC6024640 05/08/2018    
  • A group sequential test for treatment effect based on the Fine-Gray model. (Martens MJ, Logan BR) Biometrics 2018 09;74(3):1006-1013 PMID: 29534294 PMCID: PMC6146968 03/14/2018    
  • Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most. (Shaw BE, Logan BR, Spellman SR, Marsh SGE, Robinson J, Pidala J, Hurley C, Barker J, Maiers M, Dehn J, Wang H, Haagenson M, Porter D, Petersdorf EW, Woolfrey A, Horowitz MM, Verneris M, Hsu KC, Fleischhauer K, Lee SJ) Biol Blood Marrow Transplant 2018 May;24(5):1049-1056 PMID: 29454040 PMCID: PMC5953795 02/18/2018    
  • Decision making and uncertainty quantification for individualized treatments using Bayesian Additive Regression Trees. (Logan BR, Sparapani R, McCulloch RE, Laud PW) Stat Methods Med Res 2017 Jan 01:962280217746191 PMID: 29254443 PMCID: PMC6028324 12/20/2017    
  • Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study. (Heimall J, Logan BR, Cowan MJ, Notarangelo LD, Griffith LM, Puck JM, Kohn DB, Pulsipher MA, Parikh S, Martinez C, Kapoor N, O'Reilly R, Boyer M, Pai SY, Goldman F, Burroughs L, Chandra S, Kletzel M, Thakar M, Connelly J, Cuvelier G, Davila Saldana BJ, Shereck E, Knutsen A, Sullivan KE, DeSantes K, Gillio A, Haddad E, Petrovic A, Quigg T, Smith AR, Stenger E, Yin Z, Shearer WT, Fleisher T, Buckley RH, Dvorak CC) Blood 2017 12 21;130(25):2718-2727 PMID: 29021228 PMCID: PMC5746165 10/13/2017       13 Citations
  • Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34 Yields Are Less. (Stroncek DF, Shaw BE, Logan BR, Kiefer DM, Savani BN, Anderlini P, Bredeson CN, Hematti P, Ganguly S, Diaz MA, Abdel-Azim H, Ahmed I, Maharaj D, Seftel M, Beitinjaneh A, Seo S, Yared JA, Halter J, O'Donnell PV, Hale GA, DeFilipp Z, Lazarus H, Liesveld JL, Zhou Z, Munshi P, Olsson RF, Kasow KA, Szer J, Switzer GE, Chitphakdithai P, Shah N, Confer DL, Pulsipher MA) Biol Blood Marrow Transplant 2018 01;24(1):175-184 PMID: 28958894 PMCID: PMC5743544 09/30/2017    
  • Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes. (Scott BL, Pasquini MC, Logan BR, Wu J, Devine SM, Porter DL, Maziarz RT, Warlick ED, Fernandez HF, Alyea EP, Hamadani M, Bashey A, Giralt S, Geller NL, Leifer E, Le-Rademacher J, Mendizabal AM, Horowitz MM, Deeg HJ, Horwitz ME) J Clin Oncol 2017 Apr 10;35(11):1154-1161 PMID: 28380315 PMCID: PMC5455603 04/06/2017       79 Citations
  • Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post-allogeneic HCT. (Abu Zaid M, Wu J, Wu C, Logan BR, Yu J, Cutler C, Antin JH, Paczesny S, Choi SW) Blood 2017 01 12;129(2):162-170 PMID: 27827824 PMCID: PMC5234220 11/10/2016       17 Citations
  • The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes. (Artz AS, Logan B, Zhu X, Akpek G, Bufarull RM, Gupta V, Lazarus HM, Litzow M, Loren A, Majhail NS, Maziarz RT, McCarthy P, Popat U, Saber W, Spellman S, Ringden O, Wickrema A, Pasquini MC, Cooke KR, from the Center for International Blood and Marrow Transplantation Research) Haematologica 2016 11;101(11):1426-1433 PMID: 27662010 PMCID: PMC5394859 11/02/2016       13 Citations
  • A trial of unrelated donor marrow transplantation for children with severe sickle cell disease. (Shenoy S, Eapen M, Panepinto JA, Logan BR, Wu J, Abraham A, Brochstein J, Chaudhury S, Godder K, Haight AE, Kasow KA, Leung K, Andreansky M, Bhatia M, Dalal J, Haines H, Jaroscak J, Lazarus HM, Levine JE, Krishnamurti L, Margolis D, Megason GC, Yu LC, Pulsipher MA, Gersten I, DiFronzo N, Horowitz MM, Walters MC, Kamani N) Blood 2016 11 24;128(21):2561-2567 PMID: 27625358 PMCID: PMC5123194 09/15/2016       37 Citations
  • Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 Trial. (Knight JM, Syrjala KL, Majhail NS, Martens M, Le-Rademacher J, Logan BR, Lee SJ, Jacobsen PB, Wood WA, Jim HSL, Wingard JR, Horowitz MM, Abidi MH, Fei M, Rawls L, Rizzo JD) Biol Blood Marrow Transplant 2016 12;22(12):2256-2263 PMID: 27565521 PMCID: PMC5116244 08/28/2016       4 Citations
  • Comparison of Patient-Reported Outcomes in 5-Year Survivors Who Received Bone Marrow vs Peripheral Blood Unrelated Donor Transplantation: Long-term Follow-up of a Randomized Clinical Trial. (Lee SJ, Logan B, Westervelt P, Cutler C, Woolfrey A, Khan SP, Waller EK, Maziarz RT, Wu J, Shaw BE, Confer D, Horowitz MM, Anasetti C) JAMA Oncol 2016 Dec 01;2(12):1583-1589 PMID: 27532508 PMCID: PMC5145732 08/18/2016       21 Citations
  • Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysis. (O'Donnell PV, Eapen M, Horowitz MM, Logan BR, DiGilio A, Brunstein C, Fuchs EJ, Flowers ME, Salit R, Raj K, Pagliuca A, Bradstock K, Granata A, Castagna L, Furst S, Blaise D) Bone Marrow Transplant 2016 12;51(12):1599-1601 PMID: 27526284 PMCID: PMC5143194 08/16/2016       15 Citations
  • A multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic hematopoietic stem cell transplantation. (Magenau J, Westervelt P, Khaled S, McGuirk J, Hari P, Eapen M, Becker PS, Parkin B, Braun T, Logan B, Wang H, Jagasia M, Rowley SD, Kim DD, Schechter T, Frey N, Scott B, Churay T, Lieland S, Forman S, Mineishi S) Bone Marrow Transplant 2017 Jan;52(1):59-65 PMID: 27427921 PMCID: PMC5215562 07/19/2016       4 Citations
  • PSEUDO-VALUE APPROACH FOR CONDITIONAL QUANTILE RESIDUAL LIFETIME ANALYSIS FOR CLUSTERED SURVIVAL AND COMPETING RISKS DATA WITH APPLICATIONS TO BONE MARROW TRANSPLANT DATA. (Ahn KW, Logan BR) Ann Appl Stat 2016 Jun;10(2):618-637 PMID: 29081872 PMCID: PMC5656291 06/01/2016    
  • Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and High-Dose Rituximab for Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma: A Phase Two Multicenter Trial from the Blood and Marrow Transplant Clinical Trials Network. (Laport GG, Wu J, Logan B, Bachanova V, Hosing C, Fenske T, Longo W, Devine SM, Nademanee A, Gersten I, Horowitz M, Lazarus HM, Riches ML, Blood and Marrow Transplant Clinical Trials Network) Biol Blood Marrow Transplant 2016 08;22(8):1440-1448 PMID: 27118571 PMCID: PMC4949103 04/28/2016       17 Citations
  • Recovery of Unrelated Donors of Peripheral Blood Stem Cells versus Recovery of Unrelated Donors of Bone Marrow: A Prespecified Analysis from the Phase III Blood and Marrow Transplant Clinical Trials Network Protocol 0201. (Burns LJ, Logan BR, Chitphakdithai P, Miller JP, Drexler R, Spellman S, Switzer GE, Wingard JR, Anasetti C, Confer DL, Blood and Marrow Transplant Clinical Trials Network) Biol Blood Marrow Transplant 2016 06;22(6):1108-1116 PMID: 27013014 PMCID: PMC4867293 03/26/2016       7 Citations
  • Nonparametric survival analysis using Bayesian Additive Regression Trees (BART). (Sparapani RA, Logan BR, McCulloch RE, Laud PW) Stat Med 2016 07 20;35(16):2741-53 PMID: 26854022 PMCID: PMC4899272 02/09/2016       6 Citations
  • Observational Studies: Matching or Regression? (Brazauskas R, Logan BR) Biol Blood Marrow Transplant 2016 Mar;22(3):557-63 PMID: 26712591 PMCID: PMC4756459 12/30/2015       8 Citations
  • European Group for Blood and Marrow Transplantation Centers with FACT-JACIE Accreditation Have Significantly Better Compliance with Related Donor Care Standards. (Anthias C, O'Donnell PV, Kiefer DM, Yared J, Norkin M, Anderlini P, Savani BN, Diaz MA, Bitan M, Halter JP, Logan BR, Switzer GE, Pulsipher MA, Confer DL, Shaw BE) Biol Blood Marrow Transplant 2016 Mar;22(3):514-9 PMID: 26597079 PMCID: PMC4760354 11/26/2015       6 Citations
  • Significant Improvements in the Practice Patterns of Adult Related Donor Care in US Transplantation Centers. (Anthias C, Shaw BE, Kiefer DM, Liesveld JL, Yared J, Kamble RT, D'Souza A, Hematti P, Seftel MD, Norkin M, DeFilipp Z, Kasow KA, Abidi MH, Savani BN, Shah NN, Anderlini P, Diaz MA, Malone AK, Halter JP, Lazarus HM, Logan BR, Switzer GE, Pulsipher MA, Confer DL, O'Donnell PV) Biol Blood Marrow Transplant 2016 Mar;22(3):520-7 PMID: 26597080 PMCID: PMC4760616 11/26/2015       2 Citations
  • Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors. (Young JH, Logan BR, Wu J, Wingard JR, Weisdorf DJ, Mudrick C, Knust K, Horowitz MM, Confer DL, Dubberke ER, Pergam SA, Marty FM, Strasfeld LM, Brown JWM, Langston AA, Schuster MG, Kaul DR, Martin SI, Anasetti C, Blood and Marrow Transplant Clinical Trials Network Trial 0201) Biol Blood Marrow Transplant 2016 Feb;22(2):359-370 PMID: 26409243 PMCID: PMC4716871 09/27/2015       34 Citations
  • Low Socioeconomic Status, Adverse Gene Expression Profiles, and Clinical Outcomes in Hematopoietic Stem Cell Transplant Recipients. (Knight JM, Rizzo JD, Logan BR, Wang T, Arevalo JM, Ma J, Cole SW) Clin Cancer Res 2016 Jan 01;22(1):69-78 PMID: 26286914 PMCID: PMC4703514 08/20/2015       17 Citations
  • Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection Centers. (Shaw BE, Logan BR, Kiefer DM, Chitphakdithai P, Pedersen TL, Abdel-Azim H, Abidi MH, Akpek G, Diaz MA, Artz AS, Dandoy C, Gajewski JL, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Majhail NS, O'Donnell PV, Olsson RF, Savani BN, Schears RM, Stroncek DF, Switzer GE, Williams EP, Wingard JR, Wirk BM, Confer DL, Pulsipher MA) Biol Blood Marrow Transplant 2015 Oct;21(10):1830-8 PMID: 26116089 PMCID: PMC4568129 06/28/2015       6 Citations
  • Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study. (Sorror ML, Logan BR, Zhu X, Rizzo JD, Cooke KR, McCarthy PL, Ho VT, Horowitz MM, Pasquini MC) Biol Blood Marrow Transplant 2015 Aug;21(8):1479-87 PMID: 25862591 PMCID: PMC4512746 04/12/2015       39 Citations
  • Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies. (Olsson RF, Logan BR, Chaudhury S, Zhu X, Akpek G, Bolwell BJ, Bredeson CN, Dvorak CC, Gupta V, Ho VT, Lazarus HM, Marks DI, Ringdén OT, Pasquini MC, Schriber JR, Cooke KR) Leukemia 2015 Aug;29(8):1754-62 PMID: 25772027 PMCID: PMC4527886 03/17/2015       28 Citations
  • Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation. (Chen YB, Lane AA, Logan B, Zhu X, Akpek G, Aljurf M, Artz A, Bredeson CN, Cooke KR, Ho VT, Lazarus HM, Olsson R, Saber W, McCarthy P, Pasquini MC) Biol Blood Marrow Transplant 2015 Jun;21(6):1046-1053 PMID: 25687795 PMCID: PMC4426014 02/18/2015       41 Citations
  • ABO mismatch is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation. (Logan AC, Wang Z, Alimoghaddam K, Wong RM, Lai T, Negrin RS, Grumet C, Logan BR, Zhang MJ, Spellman SR, Lee SJ, Miklos DB, Center for International Blood and Marrow Transplantation) Biol Blood Marrow Transplant 2015 Apr;21(4):746-54 PMID: 25572032 PMCID: PMC4363312 01/13/2015       13 Citations
  • Effect of cord blood processing on transplantation outcomes after single myeloablative umbilical cord blood transplantation. (Ballen KK, Logan BR, Laughlin MJ, He W, Ambruso DR, Armitage SE, Beddard RL, Bhatla D, Hwang WY, Kiss JE, Koegler G, Kurtzberg J, Nagler A, Oh D, Petz LD, Price TH, Quinones RR, Ratanatharathorn V, Rizzo JD, Sazama K, Scaradavou A, Schuster MW, Sender LS, Shpall EJ, Spellman SR, Sutton M, Weitekamp LA, Wingard JR, Eapen M) Biol Blood Marrow Transplant 2015 Apr;21(4):688-95 PMID: 25543094 PMCID: PMC4359657 12/30/2014       2 Citations
  • Bone marrow or peripheral blood for reduced-intensity conditioning unrelated donor transplantation. (Eapen M, Logan BR, Horowitz MM, Zhong X, Perales MA, Lee SJ, Rocha V, Soiffer RJ, Champlin RE) J Clin Oncol 2015 Feb 01;33(4):364-9 PMID: 25534391 PMCID: PMC4302216 12/24/2014       24 Citations
  • Survival of patients with acute myeloid leukemia relapsing after allogeneic hematopoietic cell transplantation: a center for international blood and marrow transplant research study. (Bejanyan N, Weisdorf DJ, Logan BR, Wang HL, Devine SM, de Lima M, Bunjes DW, Zhang MJ) Biol Blood Marrow Transplant 2015 Mar;21(3):454-9 PMID: 25460355 PMCID: PMC4329076 12/03/2014       60 Citations
  • Comparison of non-myeloablative conditioning regimens for lymphoproliferative disorders. (Hong S, Le-Rademacher J, Artz A, McCarthy PL, Logan BR, Pasquini MC) Bone Marrow Transplant 2015 Mar;50(3):367-74 PMID: 25437248 PMCID: PMC4351124 12/02/2014       1 Citations
  • Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells from unrelated donors, a Center for International Blood and Marrow Transplant Research analysis. (Hsu JW, Wingard JR, Logan BR, Chitphakdithai P, Akpek G, Anderlini P, Artz AS, Bredeson C, Goldstein S, Hale G, Hematti P, Joshi S, Kamble RT, Lazarus HM, O'Donnell PV, Pulsipher MA, Savani BN, Schears RM, Shaw BE, Confer DL) Biol Blood Marrow Transplant 2015 Jan;21(1):165-71 PMID: 25316111 PMCID: PMC4272878 10/16/2014       11 Citations
  • Long-term survival after transplantation of unrelated donor peripheral blood or bone marrow hematopoietic cells for hematologic malignancy. (Eapen M, Logan BR, Appelbaum FR, Antin JH, Anasetti C, Couriel DR, Chen J, Maziarz RT, McCarthy PL, Nakamura R, Ratanatharathorn V, Vij R, Champlin RE) Biol Blood Marrow Transplant 2015 Jan;21(1):55-9 PMID: 25255165 PMCID: PMC4272909 09/26/2014       15 Citations
  • Phase 3 clinical trial of steroids/mycophenolate mofetil vs steroids/placebo as therapy for acute GVHD: BMT CTN 0802. (Bolaños-Meade J, Logan BR, Alousi AM, Antin JH, Barowski K, Carter SL, Goldstein SC, Hexner EO, Horowitz MM, Lee SJ, Levine JE, MacMillan ML, Martin PJ, Mendizabal AM, Nakamura R, Pasquini MC, Weisdorf DJ, Westervelt P, Ho VT) Blood 2014 Nov 20;124(22):3221-7; quiz 3335 PMID: 25170121 PMCID: PMC4239331 08/30/2014       28 Citations
  • Transplantation outcomes for severe combined immunodeficiency, 2000-2009. (Pai SY, Logan BR, Griffith LM, Buckley RH, Parrott RE, Dvorak CC, Kapoor N, Hanson IC, Filipovich AH, Jyonouchi S, Sullivan KE, Small TN, Burroughs L, Skoda-Smith S, Haight AE, Grizzle A, Pulsipher MA, Chan KW, Fuleihan RL, Haddad E, Loechelt B, Aquino VM, Gillio A, Davis J, Knutsen A, Smith AR, Moore TB, Schroeder ML, Goldman FD, Connelly JA, Porteus MH, Xiang Q, Shearer WT, Fleisher TA, Kohn DB, Puck JM, Notarangelo LD, Cowan MJ, O'Reilly RJ) N Engl J Med 2014 Jul 31;371(5):434-46 PMID: 25075835 PMCID: PMC4183064 07/31/2014       200 Citations
  • Group sequential tests for long-term survival comparisons. (Logan BR, Mo S) Lifetime Data Anal 2015 Apr;21(2):218-40 PMID: 25053470 PMCID: PMC4305035 07/24/2014    
  • Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201. (Waller EK, Logan BR, Harris WA, Devine SM, Porter DL, Mineishi S, McCarty JM, Gonzalez CE, Spitzer TR, Krijanovski OI, Linenberger ML, Woolfrey A, Howard A, Wu J, Confer DL, Anasetti C) J Clin Oncol 2014 Aug 01;32(22):2365-72 PMID: 24982459 PMCID: PMC4180368 07/02/2014       36 Citations
  • Multicenter biologic assignment trial comparing reduced-intensity allogeneic hematopoietic cell transplant to hypomethylating therapy or best supportive care in patients aged 50 to 75 with intermediate-2 and high-risk myelodysplastic syndrome: Blood and Marrow Transplant Clinical Trials Network #1102 study rationale, design, and methods. (Saber W, Le Rademacher J, Sekeres M, Logan B, Lewis M, Mendizabal A, Leifer E, Appelbaum FR, Horowitz MM, Nakamura R, Cutler CS) Biol Blood Marrow Transplant 2014 Oct;20(10):1566-72 PMID: 24972249 PMCID: PMC4169902 06/28/2014       10 Citations
  • Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation. (Armand P, Kim HT, Logan BR, Wang Z, Alyea EP, Kalaycio ME, Maziarz RT, Antin JH, Soiffer RJ, Weisdorf DJ, Rizzo JD, Horowitz MM, Saber W) Blood 2014 Jun 05;123(23):3664-71 PMID: 24744269 PMCID: PMC4047501 04/20/2014       179 Citations
  • Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation. (Pulsipher MA, Chitphakdithai P, Logan BR, Navarro WH, Levine JE, Miller JP, Shaw BE, O'Donnell PV, Majhail NS, Confer DL) Blood 2014 Jun 05;123(23):3655-63 PMID: 24735965 PMCID: PMC4047500 04/17/2014       48 Citations
  • Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: blood and marrow transplant clinical trials network protocol. (Yanik GA, Horowitz MM, Weisdorf DJ, Logan BR, Ho VT, Soiffer RJ, Carter SL, Wu J, Wingard JR, Difronzo NL, Ferrara JL, Giralt S, Madtes DK, Drexler R, White ES, Cooke KR) Biol Blood Marrow Transplant 2014 Jun;20(6):858-64 PMID: 24607553 PMCID: PMC4128626 03/13/2014       26 Citations
  • Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience. (Shearer WT, Dunn E, Notarangelo LD, Dvorak CC, Puck JM, Logan BR, Griffith LM, Kohn DB, O'Reilly RJ, Fleisher TA, Pai SY, Martinez CA, Buckley RH, Cowan MJ) J Allergy Clin Immunol 2014 Apr;133(4):1092-8 PMID: 24290292 PMCID: PMC3972266 12/03/2013       93 Citations
  • Biobehavioral measures as outcomes: a cautionary tale. (Kovach CR, Woods DL, Devine EC, Logan BR, Raff H) Res Gerontol Nurs 2014 Mar-Apr;7(2):56-65 PMID: 24158972 PMCID: PMC3965632 10/26/2013       2 Citations
  • Primary Immune Deficiency Treatment Consortium (PIDTC) report. (Griffith LM, Cowan MJ, Notarangelo LD, Kohn DB, Puck JM, Pai SY, Ballard B, Bauer SC, Bleesing JJ, Boyle M, Brower A, Buckley RH, van der Burg M, Burroughs LM, Candotti F, Cant AJ, Chatila T, Cunningham-Rundles C, Dinauer MC, Dvorak CC, Filipovich AH, Fleisher TA, Bobby Gaspar H, Gungor T, Haddad E, Hovermale E, Huang F, Hurley A, Hurley M, Iyengar S, Kang EM, Logan BR, Long-Boyle JR, Malech HL, McGhee SA, Modell F, Modell V, Ochs HD, O'Reilly RJ, Parkman R, Rawlings DJ, Routes JM, Shearer WT, Small TN, Smith H, Sullivan KE, Szabolcs P, Thrasher A, Torgerson TR, Veys P, Weinberg K, Zuniga-Pflucker JC, workshop participants) J Allergy Clin Immunol 2014 Feb;133(2):335-47 PMID: 24139498 PMCID: PMC3960312 10/22/2013       33 Citations
  • The natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the primary immune deficiency treatment consortium prospective study 6901. (Dvorak CC, Cowan MJ, Logan BR, Notarangelo LD, Griffith LM, Puck JM, Kohn DB, Shearer WT, O'Reilly RJ, Fleisher TA, Pai SY, Hanson IC, Pulsipher MA, Fuleihan R, Filipovich A, Goldman F, Kapoor N, Small T, Smith A, Chan KW, Cuvelier G, Heimall J, Knutsen A, Loechelt B, Moore T, Buckley RH) J Clin Immunol 2013 Oct;33(7):1156-64 PMID: 23818196 PMCID: PMC3784642 07/03/2013       49 Citations
  • Unrelated donor allogeneic transplantation after failure of autologous transplantation for acute myelogenous leukemia: a study from the center for international blood and marrow transplantation research. (Foran JM, Pavletic SZ, Logan BR, Agovi-Johnson MA, Pérez WS, Bolwell BJ, Bornhäuser M, Bredeson CN, Cairo MS, Camitta BM, Copelan EA, Dehn J, Gale RP, George B, Gupta V, Hale GA, Lazarus HM, Litzow MR, Maharaj D, Marks DI, Martino R, Maziarz RT, Rowe JM, Rowlings PA, Savani BN, Savoie ML, Szer J, Waller EK, Wiernik PH, Weisdorf DJ) Biol Blood Marrow Transplant 2013 Jul;19(7):1102-8 PMID: 23632091 PMCID: PMC3691352 05/02/2013       12 Citations
  • Peripheral-blood versus bone marrow stem cells. (Anasetti C, Logan BR, Confer DL, Blood and Marrow Transplant Clinical Trials Network) N Engl J Med 2013 01 17;368(3):288 PMID: 23323911 01/18/2013       10 Citations
  • Lymphocyte phenotype during therapy for acute graft-versus-host disease: a brief report from BMT-CTN 0302. (Bolaños-Meade J, Wu J, Logan BR, Levine JE, Ho VT, Alousi AM, Weisdorf DJ, Luznik L, Blood and Marrow Transplant Clinical Trials Network) Biol Blood Marrow Transplant 2013 Mar;19(3):481-5 PMID: 23247045 PMCID: PMC3653300 12/19/2012       5 Citations
  • Effects of spleen status on early outcomes after hematopoietic cell transplantation. (Akpek G, Pasquini MC, Logan B, Agovi MA, Lazarus HM, Marks DI, Bornhaeüser M, Ringdén O, Maziarz RT, Gupta V, Popat U, Maharaj D, Bolwell BJ, Rizzo JD, Ballen KK, Cooke KR, McCarthy PL, Ho VT) Bone Marrow Transplant 2013 Jun;48(6):825-31 PMID: 23222382 PMCID: PMC3606905 12/12/2012       19 Citations
  • Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program. (Pulsipher MA, Chitphakdithai P, Logan BR, Shaw BE, Wingard JR, Lazarus HM, Waller EK, Seftel M, Stroncek DF, Lopez AM, Maharaj D, Hematti P, O'Donnell PV, Loren AW, Leitman SF, Anderlini P, Goldstein SC, Levine JE, Navarro WH, Miller JP, Confer DL) Blood 2013 Jan 03;121(1):197-206 PMID: 23109243 PMCID: PMC3538330 10/31/2012       61 Citations
  • Review of multistate models in hematopoietic cell transplantation studies. (Logan BR) Biol Blood Marrow Transplant 2013 Jan;19(1 Suppl):S84-7 PMID: 23084957 PMCID: PMC3867133 10/23/2012       3 Citations
  • Peripheral-blood stem cells versus bone marrow from unrelated donors. (Anasetti C, Logan BR, Lee SJ, Waller EK, Weisdorf DJ, Wingard JR, Cutler CS, Westervelt P, Woolfrey A, Couban S, Ehninger G, Johnston L, Maziarz RT, Pulsipher MA, Porter DL, Mineishi S, McCarty JM, Khan SP, Anderlini P, Bensinger WI, Leitman SF, Rowley SD, Bredeson C, Carter SL, Horowitz MM, Confer DL, Blood and Marrow Transplant Clinical Trials Network) N Engl J Med 2012 Oct 18;367(16):1487-96 PMID: 23075175 PMCID: PMC3816375 10/19/2012    
  • Comparison of the effectiveness of two protocols for treating nursing home residents with advanced dementia. (Kovach CR, Simpson MR, Joosse L, Logan BR, Noonan PE, Reynolds SA, Woods DL, Raff H) Res Gerontol Nurs 2012 Oct;5(4):251-63 PMID: 22998656 PMCID: PMC3475742 09/25/2012       13 Citations
  • The use of group sequential designs with common competing risks tests. (Logan BR, Zhang MJ) Stat Med 2013 Mar 15;32(6):899-913 PMID: 22945865 PMCID: PMC3574186 09/05/2012       6 Citations
  • A perspective on the selection of unrelated donors and cord blood units for transplantation. (Spellman SR, Eapen M, Logan BR, Mueller C, Rubinstein P, Setterholm MI, Woolfrey AE, Horowitz MM, Confer DL, Hurley CK, National Marrow Donor Program, Center for International Blood and Marrow Transplant Research) Blood 2012 Jul 12;120(2):259-65 PMID: 22596257 PMCID: PMC3398760 05/19/2012       92 Citations
  • Comparison of outcomes after HLA-matched sibling and unrelated donor transplantation for children with high-risk acute lymphoblastic leukemia. (Zhang MJ, Davies SM, Camitta BM, Logan B, Tiedemann K, Eapen M, Thiel EL) Biol Blood Marrow Transplant 2012 Aug;18(8):1204-10 PMID: 22406037 PMCID: PMC3890239 03/13/2012       29 Citations
  • Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study. (Levine JE, Logan BR, Wu J, Alousi AM, Bolaños-Meade J, Ferrara JL, Ho VT, Weisdorf DJ, Paczesny S) Blood 2012 Apr 19;119(16):3854-60 PMID: 22383800 PMCID: PMC3335389 03/03/2012       103 Citations
  • Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial. (Krishnan A, Pasquini MC, Logan B, Stadtmauer EA, Vesole DH, Alyea E 3rd, Antin JH, Comenzo R, Goodman S, Hari P, Laport G, Qazilbash MH, Rowley S, Sahebi F, Somlo G, Vogl DT, Weisdorf D, Ewell M, Wu J, Geller NL, Horowitz MM, Giralt S, Maloney DG, Blood Marrow Transplant Clinical Trials Network (BMT CTN)) Lancet Oncol 2011 Dec;12(13):1195-203 PMID: 21962393 PMCID: PMC3611089 10/04/2011       168 Citations
  • Failure to identify behavioral symptoms of people with dementia and the need for follow-up physical assessment. (Kovach CR, Logan BR, Joosse LL, Noonan PE) Res Gerontol Nurs 2012 Apr;5(2):89-93 PMID: 21598865 PMCID: PMC3161167 05/24/2011       3 Citations
  • Diurnal variation of cortisol in people with dementia: relationship to cognition and illness burden. (Kovach CR, Woods DL, Logan BR, Raff H) Am J Alzheimers Dis Other Demen 2011 Mar;26(2):145-50 PMID: 21273205 PMCID: PMC3060946 01/29/2011    
  • Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made? (Horan JT, Logan BR, Agovi-Johnson MA, Lazarus HM, Bacigalupo AA, Ballen KK, Bredeson CN, Carabasi MH, Gupta V, Hale GA, Khoury HJ, Juckett MB, Litzow MR, Martino R, McCarthy PL, Smith FO, Rizzo JD, Pasquini MC) J Clin Oncol 2011 Mar 01;29(7):805-13 PMID: 21220593 PMCID: PMC3068057 01/12/2011       94 Citations
  • HLA-matched sibling bone marrow transplantation for β-thalassemia major. (Sabloff M, Chandy M, Wang Z, Logan BR, Ghavamzadeh A, Li CK, Irfan SM, Bredeson CN, Cowan MJ, Gale RP, Hale GA, Horan J, Hongeng S, Eapen M, Walters MC) Blood 2011 Feb 03;117(5):1745-50 PMID: 21119108 PMCID: PMC3056598 12/02/2010       70 Citations
  • Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis. (Gupta V, Tallman MS, He W, Logan BR, Copelan E, Gale RP, Khoury HJ, Klumpp T, Koreth J, Lazarus HM, Marks DI, Martino R, Rizzieri DA, Rowe JM, Sabloff M, Waller EK, DiPersio JF, Bunjes DW, Weisdorf DJ) Blood 2010 Sep 16;116(11):1839-48 PMID: 20538804 PMCID: PMC3173984 06/12/2010       110 Citations
  • Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults. (Navarro WH, Agovi MA, Logan BR, Ballen K, Bolwell BJ, Frangoul H, Gupta V, Hahn T, Ho VT, Juckett M, Lazarus HM, Litzow MR, Liesveld JL, Moreb JS, Marks DI, McCarthy PL, Pasquini MC, Rizzo JD) Biol Blood Marrow Transplant 2010 Oct;16(10):1442-50 PMID: 20412867 PMCID: PMC2933950 04/24/2010       42 Citations
  • Marginal models for clustered time-to-event data with competing risks using pseudovalues. (Logan BR, Zhang MJ, Klein JP) Biometrics 2011 Mar;67(1):1-7 PMID: 20377579 PMCID: PMC2902638 04/10/2010       15 Citations
  • Factors associated with time to identify physical problems of nursing home residents with dementia. (Kovach CR, Logan BR, Simpson MR, Reynolds S) Am J Alzheimers Dis Other Demen 2010 Jun;25(4):317-23 PMID: 20237337 PMCID: PMC2884077 03/20/2010       15 Citations
  • The effect of smoking on allogeneic transplant outcomes. (Marks DI, Ballen K, Logan BR, Wang Z, Sobocinski KA, Bacigalupo A, Burns LJ, Gupta V, Ho V, McCarthy PL, Ringdén O, Schouten HC, Seftel M, Rizzo JD) Biol Blood Marrow Transplant 2009 Oct;15(10):1277-87 PMID: 19747636 PMCID: PMC2768519 09/15/2009       17 Citations
  • Prognostic impact of C-REL expression in diffuse large B-cell lymphoma. (Curry CV, Ewton AA, Olsen RJ, Logan BR, Preti HA, Liu YC, Perkins SL, Chang CC) J Hematop 2009 Mar;2(1):20-6 PMID: 19669219 PMCID: PMC2713494 08/12/2009    
  • Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose. (Pulsipher MA, Chitphakdithai P, Logan BR, Leitman SF, Anderlini P, Klein JP, Horowitz MM, Miller JP, King RJ, Confer DL) Blood 2009 Sep 24;114(13):2606-16 PMID: 19608747 PMCID: PMC2756121 07/18/2009       79 Citations
  • Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network. (Alousi AM, Weisdorf DJ, Logan BR, Bolaños-Meade J, Carter S, Difronzo N, Pasquini M, Goldstein SC, Ho VT, Hayes-Lattin B, Wingard JR, Horowitz MM, Levine JE, Blood and Marrow Transplant Clinical Trials Network) Blood 2009 Jul 16;114(3):511-7 PMID: 19443659 PMCID: PMC2713466 05/16/2009       136 Citations
  • Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomes. (van Besien K, Carreras J, Bierman PJ, Logan BR, Molina A, King R, Nelson G, Fay JW, Champlin RE, Lazarus HM, Vose JM, Hari PN) Biol Blood Marrow Transplant 2009 May;15(5):554-63 PMID: 19361747 PMCID: PMC3120935 04/14/2009       27 Citations
  • Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. (Pulsipher MA, Chitphakdithai P, Miller JP, Logan BR, King RJ, Rizzo JD, Leitman SF, Anderlini P, Haagenson MD, Kurian S, Klein JP, Horowitz MM, Confer DL) Blood 2009 Apr 09;113(15):3604-11 PMID: 19190248 PMCID: PMC2668845 02/05/2009       149 Citations
  • Methods for equivalence and noninferiority testing. (Tunes da Silva G, Logan BR, Klein JP) Biol Blood Marrow Transplant 2009 Jan;15(1 Suppl):120-7 PMID: 19147090 PMCID: PMC2701110 01/29/2009       50 Citations
  • Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma. (Devetten MP, Hari PN, Carreras J, Logan BR, van Besien K, Bredeson CN, Freytes CO, Gale RP, Gibson J, Giralt SA, Goldstein SC, Gupta V, Marks DI, Maziarz RT, Vose JM, Lazarus HM, Anderlini P) Biol Blood Marrow Transplant 2009 Jan;15(1):109-17 PMID: 19135949 PMCID: PMC2929570 01/13/2009       73 Citations
  • Use of biological assignment in hematopoietic stem cell transplantation clinical trials. (Logan B, Leifer E, Bredeson C, Horowitz M, Ewell M, Carter S, Geller N) Clin Trials 2008;5(6):607-16 PMID: 19029209 PMCID: PMC2671015 11/26/2008       16 Citations
  • Superiority inferences on individual endpoints following noninferiority testing in clinical trials. (Logan BR, Tamhane AC) Biom J 2008 Oct;50(5):693-703 PMID: 18932132 10/22/2008       11 Citations
  • Analyzing center specific outcomes in hematopoietic cell transplantation. (Logan BR, Nelson GO, Klein JP) Lifetime Data Anal 2008 Dec;14(4):389-404 PMID: 18836830 PMCID: PMC2709496 10/07/2008       10 Citations
  • Inference for current leukemia free survival. (Liu L, Logan B, Klein JP) Lifetime Data Anal 2008 Dec;14(4):432-46 PMID: 18663574 PMCID: PMC2715962 07/30/2008       8 Citations
  • Behavior modification and risk perception in patients with nonmelanoma skin cancer. (Rhee JS, Davis-Malesevich M, Logan BR, Neuburg M, Burzynski M, Nattinger AB) WMJ 2008 Apr;107(2):62-8 PMID: 18593080 PMCID: PMC3590063 07/03/2008       15 Citations
  • On the probability of using cord blood. (Nietfeld JJ, Pasquini MC, Logan BR, Verter F, Horowitz MM) Biol Blood Marrow Transplant 2008 Jun;14(6):724-5 PMID: 18489999 05/21/2008       4 Citations
  • Use of cost-effectiveness analysis to determine inventory size for a national cord blood bank. (Howard DH, Meltzer D, Kollman C, Maiers M, Logan B, Gragert L, Setterholm M, Horowitz MM) Med Decis Making 2008 Mar-Apr;28(2):243-53 PMID: 18349441 03/20/2008       31 Citations
  • Lifetime probabilities of hematopoietic stem cell transplantation in the U.S. (Nietfeld JJ, Pasquini MC, Logan BR, Verter F, Horowitz MM) Biol Blood Marrow Transplant 2008 Mar;14(3):316-22 PMID: 18275898 PMCID: PMC2531159 02/16/2008       40 Citations
  • Comparing treatments in the presence of crossing survival curves: an application to bone marrow transplantation. (Logan BR, Klein JP, Zhang MJ) Biometrics 2008 Sep;64(3):733-40 PMID: 18190619 PMCID: PMC2754119 01/15/2008       32 Citations
  • State of the art review: HLA matching and outcome of unrelated donor umbilical cord blood transplants. (Kamani N, Spellman S, Hurley CK, Barker JN, Smith FO, Oudshoorn M, Bray R, Smith A, Williams TM, Logan B, Eapen M, Anasetti C, Setterholm M, Confer DL, National Marrow Donor Program) Biol Blood Marrow Transplant 2008 Jan;14(1):1-6 PMID: 18158954 12/27/2007       63 Citations
  • Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research. (Bishop MR, Logan BR, Gandham S, Bolwell BJ, Cahn JY, Lazarus HM, Litzow MR, Marks DI, Wiernik PH, McCarthy PL, Russell JA, Miller CB, Sierra J, Milone G, Keating A, Loberiza FR Jr, Giralt S, Horowitz MM, Weisdorf DJ) Bone Marrow Transplant 2008 Apr;41(7):635-42 PMID: 18084335 PMCID: PMC2587442 12/18/2007       34 Citations
  • An evaluation of spatial thresholding techniques in fMRI analysis. (Logan BR, Geliazkova MP, Rowe DB) Hum Brain Mapp 2008 Dec;29(12):1379-89 PMID: 18064589 12/08/2007       23 Citations
  • Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival. (Eapen M, Logan BR, Confer DL, Haagenson M, Wagner JE, Weisdorf DJ, Wingard JR, Rowley SD, Stroncek D, Gee AP, Horowitz MM, Anasetti C) Biol Blood Marrow Transplant 2007 Dec;13(12):1461-8 PMID: 18022576 PMCID: PMC2267869 11/21/2007       129 Citations
  • Utility of single versus tandem autotransplants for advanced testes/germ cell cancer: a center for international blood and marrow transplant research (CIBMTR) analysis. (Lazarus HM, Stiff PJ, Carreras J, Logan BR, Akard L, Bolwell BJ, Childs RW, Gale RP, Klein JP, Lill MC, Pérez WS, Stadtmauer EA, Rizzo JD) Biol Blood Marrow Transplant 2007 Jul;13(7):778-89 PMID: 17580256 06/21/2007       8 Citations
  • Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: long-term follow-up of the first 285 reported to the national marrow donor program. (Giralt S, Logan B, Rizzo D, Zhang MJ, Ballen K, Emmanouilides C, Nath R, Parker P, Porter D, Sandmaier B, Waller EK, Barker J, Pavletic S, Weisdorf D) Biol Blood Marrow Transplant 2007 Jul;13(7):844-52 PMID: 17580263 06/21/2007       52 Citations
  • Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission. (Tallman MS, Dewald GW, Gandham S, Logan BR, Keating A, Lazarus HM, Litzow MR, Mehta J, Pedersen T, Pérez WS, Rowe JM, Wetzler M, Weisdorf DJ) Blood 2007 Jul 01;110(1):409-17 PMID: 17374741 PMCID: PMC1896123 03/22/2007       54 Citations
  • Homeostatic expansion and repertoire regeneration of donor T cells during graft versus host disease is constrained by the host environment. (Gorski J, Chen X, Gendelman M, Yassai M, Krueger A, Tivol E, Logan B, Komorowski R, Vodanovic-Jankovic S, Drobyski WR) Blood 2007 Jun 15;109(12):5502-10 PMID: 17347406 PMCID: PMC1890817 03/10/2007       13 Citations
  • Analyzing survival curves at a fixed point in time. (Klein JP, Logan B, Harhoff M, Andersen PK) Stat Med 2007 Oct 30;26(24):4505-19 PMID: 17348080 03/10/2007       120 Citations
  • The skin cancer index: clinical responsiveness and predictors of quality of life. (Rhee JS, Matthews BA, Neuburg M, Logan BR, Burzynski M, Nattinger AB) Laryngoscope 2007 Mar;117(3):399-405 PMID: 17334300 PMCID: PMC1847346 03/06/2007       60 Citations
  • Effects of gadolinium on regionally stunned myocardium: temporal considerations. (Nicolosi AC, Kwok CS, Logan B) J Surg Res 2007 May 15;139(2):286-91 PMID: 17270216 02/03/2007       4 Citations
  • Validation of a quality-of-life instrument for patients with nonmelanoma skin cancer. (Rhee JS, Matthews BA, Neuburg M, Logan BR, Burzynski M, Nattinger AB) Arch Facial Plast Surg 2006 Sep-Oct;8(5):314-8 PMID: 16982987 PMCID: PMC2556600 09/20/2006       56 Citations
  • Effects of the Serial Trial Intervention on discomfort and behavior of nursing home residents with dementia. (Kovach CR, Logan BR, Noonan PE, Schlidt AM, Smerz J, Simpson M, Wells T) Am J Alzheimers Dis Other Demen 2006 Jun-Jul;21(3):147-55 PMID: 16869334 07/28/2006    
  • Regression models for hazard rates versus cumulative incidence probabilities in hematopoietic cell transplantation data. (Logan BR, Zhang MJ, Klein JP) Biol Blood Marrow Transplant 2006 Jan;12(1 Suppl 1):107-12 PMID: 16399594 01/10/2006       22 Citations
  • Optimal two-stage randomized phase II clinical trials. (Logan BR) Clin Trials 2005;2(1):5-12 PMID: 16279574 11/11/2005       6 Citations
  • Reliability of biomechanical spasticity measurements at the elbow of people poststroke. (Starsky AJ, Sangani SG, McGuire JR, Logan B, Schmit BD) Arch Phys Med Rehabil 2005 Aug;86(8):1648-54 PMID: 16084821 08/09/2005       49 Citations
  • Pairwise multiple comparison adjustment in survival analysis. (Logan BR, Wang H, Zhang MJ) Stat Med 2005 Aug 30;24(16):2509-23 PMID: 15977296 06/25/2005       12 Citations
  • Clinical risk factors associated with bleeding after native kidney biopsy. (Shidham GB, Siddiqi N, Beres JA, Logan B, Nagaraja HN, Shidham SG, Piering WF) Nephrology (Carlton) 2005 Jun;10(3):305-10 PMID: 15958047 06/17/2005       66 Citations
  • The implication of follicular lymphoma patients receiving allogeneic stem cell transplantation from donors carrying t(14;18)-positive cells. (McGregor DK, Keever-Taylor CA, Bredeson C, Schur B, Vesole DH, Logan B, Chang CC) Bone Marrow Transplant 2005 Jun;35(11):1049-54 PMID: 15821762 04/12/2005       4 Citations
  • Complex fMRI analysis with unrestricted phase is equivalent to a magnitude-only model. (Rowe DB, Logan BR) Neuroimage 2005 Jan 15;24(2):603-6 PMID: 15627605 01/04/2005       30 Citations
  • Finding the maximum safe dose level for heteroscedastic data. (Tamhane AC, Logan BR) J Biopharm Stat 2004 Nov;14(4):843-56 PMID: 15587967 12/14/2004       8 Citations
  • A complex way to compute fMRI activation. (Rowe DB, Logan BR) Neuroimage 2004 Nov;23(3):1078-92 PMID: 15528108 11/06/2004       69 Citations
  • Temporal discordance between graft-versus-leukemia and graft-versus-host responses: a strategy for the separation of graft-versus-leukemia/graft-versus-host reactivity? (Hari P, Logan B, Drobyski WR) Biol Blood Marrow Transplant 2004 Nov;10(11):743-7 PMID: 15505605 10/27/2004       7 Citations
  • Routine screening for psychosocial distress following hematopoietic stem cell transplantation. (Lee SJ, Loberiza FR, Antin JH, Kirkpatrick T, Prokop L, Alyea EP, Cutler C, Ho VT, Richardson PG, Schlossman RL, Fisher DC, Logan B, Soiffer RJ) Bone Marrow Transplant 2005 Jan;35(1):77-83 PMID: 15502851 10/27/2004       74 Citations
  • Alpha phenyl-tert-butyl nitrone (PBN) protects syngeneic marrow transplant recipients from the lethal cytokine syndrome occurring after agonistic CD40 antibody administration. (Gendelman M, Halligan N, Komorowski R, Logan B, Murphy WJ, Blazar BR, Pritchard KA Jr, Drobyski WR) Blood 2005 Jan 01;105(1):428-31 PMID: 15331451 08/28/2004       8 Citations
  • An evaluation of thresholding techniques in fMRI analysis. (Logan BR, Rowe DB) Neuroimage 2004 May;22(1):95-108 PMID: 15110000 04/28/2004       89 Citations
  • Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma. (Chang CC, McClintock S, Cleveland RP, Trzpuc T, Vesole DH, Logan B, Kajdacsy-Balla A, Perkins SL) Am J Surg Pathol 2004 Apr;28(4):464-70 PMID: 15087665 04/17/2004       210 Citations
  • Reproducibility of spinal back-contour measurements taken with raster stereography in adolescent idiopathic scoliosis. (Lyon R, Liu XC, Thometz JG, Nelson ER, Logan B) Am J Orthop (Belle Mead NJ) 2004 Feb;33(2):67-70 PMID: 15005595 03/10/2004       12 Citations
  • National Marrow Donor Program HLA-matching guidelines for unrelated marrow transplants. (Hurley CK, Baxter Lowe LA, Logan B, Karanes C, Anasetti C, Weisdorf D, Confer DL) Biol Blood Marrow Transplant 2003 Oct;9(10):610-5 PMID: 14569557 10/22/2003       70 Citations
  • Tumor load in patients with follicular lymphoma post stem cell transplantation may correlate with clinical course. (Chang CC, Bredeson C, Juckett M, Logan B, Keever-Taylor CA) Bone Marrow Transplant 2003 Aug;32(3):287-91 PMID: 12858200 07/15/2003       13 Citations
  • Expression of p53, c-Myc, or Bcl-6 suggests a poor prognosis in primary central nervous system diffuse large B-cell lymphoma among immunocompetent individuals. (Chang CC, Kampalath B, Schultz C, Bunyi-Teopengco E, Logan B, Eshoa C, Dincer AP, Perkins SL) Arch Pathol Lab Med 2003 Feb;127(2):208-12 PMID: 12562237 02/04/2003       59 Citations
  • Expression of MUM1/IRF4 correlates with clinical outcome in patients with B-cell chronic lymphocytic leukemia. (Chang CC, Lorek J, Sabath DE, Li Y, Chitambar CR, Logan B, Kampalath B, Cleveland RP) Blood 2002 Dec 15;100(13):4671-5 PMID: 12393648 10/24/2002       44 Citations
  • Accurate critical constants for the one-sided approximate likelihood ratio test of a normal mean vector when the covariance matrix is estimated. (Tamhane AC, Logan BR) Biometrics 2002 Sep;58(3):650-6 PMID: 12230000 09/17/2002       12 Citations
  • Gadolinium attenuates regional stunning in the canine heart in vivo. (Nicolosi AC, West G, Markley JG, Logan B, Olinger GN) J Thorac Cardiovasc Surg 2002 Jul;124(1):57-62 PMID: 12091809 07/02/2002       7 Citations
  • Last update: 12/05/2018
    jenkins-FCD Prod-288 ba989beae37c4807010653a17407cd2d1f5e0810